{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:30:13Z","timestamp":1784809813598,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bilateral salpingectomy has been proposed to reduce the risk of ovarian cancer, but it is not clear whether the surgery affects ovarian reserve. This study compares the impact of laparoscopic hysterectomy for benign disease with or without prophylactic bilateral salpingectomy on ovarian reserve.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Records were reviewed for 373 premenopausal women who underwent laparoscopic hysterectomy with ovarian reserve for benign uterine diseases. The serum anti-M\u00fcllerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and three-dimensional antral follicle count (AFC) were assessed before surgery and 3 and 9 months postoperatively to evaluate ovarian reserve. Patients were divided into two groups according to whether they underwent prophylactic bilateral salpingectomy. The incidence of pelvic diseases was monitored until the ninth month after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was no significant difference between the two surgery groups in terms of baseline AMH, E2, FSH, LH, and AFC (all <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). There was no difference in potential bias factors, including patient age, operative time, and blood loss (all <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). There was also no significant difference between the two groups 3 months after surgery with respect to AMH (<jats:italic>P<\/jats:italic>\u2009=\u20090.763), E2 (<jats:italic>P<\/jats:italic>\u2009=\u20090.264), FSH (<jats:italic>P<\/jats:italic>\u2009=\u20090.478), LH (<jats:italic>P<\/jats:italic>\u2009=\u20090.07), and AFC (<jats:italic>P<\/jats:italic>\u2009=\u20090.061). Similarly, there were no differences between groups 9 months after surgery for AMH (<jats:italic>P<\/jats:italic>\u2009=\u20090.939), E2 (<jats:italic>P<\/jats:italic>\u2009=\u20090.137), FSH (<jats:italic>P<\/jats:italic>\u2009=\u20090.276), LH (<jats:italic>P<\/jats:italic>\u2009=\u20090.07) and AFC (<jats:italic>P<\/jats:italic>\u2009=\u20090.066). At 9 months after the operation, no patients had malignant ovarian tumors. The incidences of benign ovarian tumors in the salpingectomy group were 0 and 2.68\u2009% at 3 and 9 months after surgery, respectively, and the corresponding values in the control group were 0 and 5.36\u2009%. The incidences of pelvic inflammatory disease in the salpingectomy group were 10.72 and 8.04\u2009% at 3 and 9 months after surgery, respectively, while corresponding values in the control group were 24.13 and 16.09\u2009%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Prophylactic bilateral salpingectomy did not damage the ovarian reserve of reproductive-age women who underwent laparoscopic hysterectomy. Prophylactic bilateral salpingectomy might be a good method to prevent the development of ovarian cancer. Larger clinical trials with longer follow-up times are needed to further evaluate the risks and benefits.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-021-00825-w","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T22:02:29Z","timestamp":1625004149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The effect of prophylactic bilateral salpingectomy on ovarian reserve in patients who underwent laparoscopic hysterectomy"],"prefix":"10.1186","volume":"14","author":[{"given":"Shizhuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"825_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393:124\u201353.","journal-title":"Lancet"},{"key":"825_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun. 2017;8:1093.","journal-title":"Nat Commun"},{"issue":"Suppl 10","key":"825_CR3","doi-asserted-by":"publisher","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","volume":"24","author":"RJ Kurman","year":"2013","unstructured":"Kurman RJ. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol. 2013;24(Suppl 10):x16\u201321.","journal-title":"Ann Oncol"},{"key":"825_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejogrb.2016.07.483","volume":"204","author":"MA Atalay","year":"2016","unstructured":"Atalay MA, Cetinkaya Demir B, Ozerkan K. Change in the ovarian environment after hysterectomy with bilateral salpingectomy: Is it the technique or surgery itself ? Eur J Obstet Gynecol Reprod Biol. 2016;204:57\u201361.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"825_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13048-019-0504-6","volume":"12","author":"X Chao","year":"2019","unstructured":"Chao X, Wang X, Xiao Y, Ji M, Wang S, Shi H, Fan Q, Zhu L, Leng J, Sun D, Lang J. Effects of hysterectomy with simultaneous bilateral salpingectomy on the subsequent pelvic mass. J Ovarian Res. 2019;12(1):27.","journal-title":"J Ovarian Res"},{"issue":"7","key":"825_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/1471-0528.15651","volume":"126","author":"F Gaba","year":"2019","unstructured":"Gaba F, Piek J, Menon U, Manchanda R. Risk-reducing early salpingectomy and delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in women at increased risk: a commentary. BJOG. 2019;126(7):831\u20139.","journal-title":"BJOG"},{"key":"825_CR7","doi-asserted-by":"crossref","unstructured":"Roberta Venturella M, Morelli D, Lico AD, Cello M, Rocca A, Sacchinelli R, Mocciaro PD\u2019Alessandro, Maiorana A, Gizzo S, Fulvio Zullo. Wide excision of soft tissues adjacent to the ovary and fallopian tube does not impair the ovarian reserve in women undergoing prophylactic bilateral salpingectomy: results from a randomized, controlled trial. Fertil Steril. 2015;104(5):1332\u20139.","DOI":"10.1016\/j.fertnstert.2015.08.004"},{"issue":"2","key":"825_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jmig.2016.12.001","volume":"24","author":"MA Stuparich","year":"2017","unstructured":"Stuparich MA, Lee TTM. Tips and Tricks for Performing Salpingectomy at the Time of Laparoscopic Hysterectomy. J Minim Invasive Gynecol. 2017;24(2):205.","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"825_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jmig.2017.03.013","volume":"25","author":"SA Scheib","year":"2018","unstructured":"Scheib SA. A Laparoendoscopic Single-site Surgical Approach to Laparoscopic Salpingectomy. J Minim Invasive Gynecol. 2018;25(2):326\u20137.","journal-title":"J Minim Invasive Gynecol"},{"issue":"1","key":"825_CR10","doi-asserted-by":"publisher","first-page":"85.e1","DOI":"10.1016\/j.ajog.2018.10.016","volume":"220","author":"E Collins","year":"2019","unstructured":"Collins E, Strandell A, Gran\u00e5sen G, Idahl A. Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study. Am J Obstet Gynecol. 2019;220(1):85.e1-85.e10.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"825_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13048-020-00678-9","volume":"13","author":"T Chen","year":"2020","unstructured":"Chen T, Zhao F, Wang Q, Liu C, Lan Y, Wang S, Xin Z, Yang X. Salpingectomy may decrease antral follicle count but not live birth rate for IVF-ET patients aged 35\u201339 years: a retrospective study. J Ovarian Res. 2020;13(1):80.","journal-title":"J Ovarian Res"},{"key":"825_CR12","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/j.fertnstert.2013.12.020","volume":"101","author":"J Dietl","year":"2014","unstructured":"Dietl J, Wischhusen J. The postreproductive salpingectomy. Fertil Steril. 2014;101:e20.","journal-title":"Fertil Steril"},{"key":"825_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fendo.2019.00281","volume":"10","author":"R Tal","year":"2019","unstructured":"Tal R, Seifer DB. Ovarian reserve testing: a user\u2019s guide. Front Endocrinol (Lausanne). 2019;10:281.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"825_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/13625187.2019.1702158","volume":"25","author":"SK Landersoe","year":"2020","unstructured":"Landersoe SK, Forman JL, Birch Petersen K, Larsen EC, N\u00f8hr B, Hvidman HW, Nielsen HS, Nyboe Andersen A. Ovarian reserve markers in women using various hormonal contraceptives. Eur J Contracept Reprod Health Care. 2020;25(1):65\u201371.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"9","key":"825_CR15","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00018-019-03028-1","volume":"76","author":"W Ge","year":"2019","unstructured":"Ge W, Li L, Dyce PW, De Felici M, Shen W. Establishment and depletion of the ovarian reserve: physiology and impact of environmental chemicals. Cell Mol Life Sci. 2019;76(9):1729\u201346.","journal-title":"Cell Mol Life Sci"},{"issue":"14","key":"825_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jama.2017.14588","volume":"318","author":"Z Anne","year":"2017","unstructured":"Anne Z, Steiner D, Pritchard FZ, Stanczyk JS, Kesner JW, Meadows AH, Herring. Donna D Baird. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Reproductive Age Women. JAMA. 2017;318(14):1367\u201376.","journal-title":"JAMA"},{"issue":"1","key":"825_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12884-019-2578-y","volume":"19","author":"H Erfani","year":"2019","unstructured":"Erfani H, Rahmati M, Mansournia MA, Azizi F, Montazeri SA, Shamshirsaz AA, Ramezani Tehrani F. Association between ovarian reserve and preeclampsia: a cohort study. BMC Pregnancy Childbirth. 2019;19(1):432.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"8","key":"825_CR18","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/humrep\/dey238","volume":"33","author":"SJ Morin","year":"2018","unstructured":"Morin SJ, Patounakis G, Juneau CR, Neal SA, Scott RT, Seli E. Diminished ovarian reserve and poor response to stimulation in patients < 38 years old: a quantitative but not qualitative reduction in performance. Hum Reprod. 2018;33(8):1489\u201398.","journal-title":"Hum Reprod"},{"key":"825_CR19","first-page":"2306","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:2306.","journal-title":"Am J Surg Pathol"},{"key":"825_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3747\/co.20.1613","volume":"20","author":"WD Foulkes","year":"2013","unstructured":"Foulkes WD. Preventing ovarian cancer by salpingectomy. Curr Oncol. 2013;20:139 \u2013 42.","journal-title":"Curr Oncol"},{"issue":"4","key":"825_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/ijms20040952","volume":"20","author":"MA Lisio","year":"2019","unstructured":"Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C. High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints. Int J Mol Sci. 2019;20(4):952.","journal-title":"Int J Mol Sci"},{"key":"825_CR22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.fertnstert.2012.08.009","volume":"98","author":"E Somigliana","year":"2012","unstructured":"Somigliana E, Berlanda N, Benaglia L, Vigano P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antim\u1e7bllerian hormone level modifications. Fertil Steril. 2012;98:1531\u20138.","journal-title":"Fertil Steril"},{"key":"825_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.rbmo.2011.07.014","volume":"23","author":"C Biacchiardi","year":"2011","unstructured":"Biacchiardi C, Piane L, Camanni M, Deltetto F, Delpiano EM, Marchino GL, et al. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod Biomed Online. 2011;23:740\u20136.","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"825_CR24","first-page":"CD012858","volume":"8","author":"LAM van Lieshout","year":"2019","unstructured":"van Lieshout LAM, Steenbeek MP, De Hullu JA, Vos MC, Houterman S, Wilkinson J, Piek JM. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone. Cochrane Database Syst Rev. 2019;8(8):CD012858.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"825_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4103\/0973-1482.193114","volume":"14","author":"Z Asgari","year":"2018","unstructured":"Asgari Z, Tehranian A, Rouholamin S, Hosseini R, Sepidarkish M, Rezainejad M. Comparing surgical outcome and ovarian reserve after laparoscopic hysterectomy between two methods of with and without prophylactic bilateral salpingectomy: A randomized controlled trial. J Cancer Res Ther. 2018;14(3):543\u20138.","journal-title":"J Cancer Res Ther"},{"key":"825_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","volume":"129","author":"M Morelli","year":"2013","unstructured":"Morelli M, Venturella R, Mocciaro R, Di Cello A, Rania E, Lico D, et al. Prophylactic salpingectomy in premenopausal low risk women for ovarian cancer: primumnon nocere. Gynecol Oncol. 2013;129:448\u201351.","journal-title":"Gynecol Oncol"},{"key":"825_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","volume":"125","author":"JS Kwon","year":"2015","unstructured":"Kwon JS, McAlpine JN, Hanley GE, Finlayson SJ, Cohen T, Miller DM, et al. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy. Obstet Gynecol. 2015;125:338\u201345.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"825_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.24920\/J1001-9294.2017.022","volume":"32","author":"S Dhakal","year":"2017","unstructured":"Dhakal S, Zheng YX, Yi XF. Current Updates on Salpingectomy for the Prevention of Ovarian Cancer and Its Practice Patterns Worldwide. Chin Med Sci J. 2017;32(3):185\u201392.","journal-title":"Chin Med Sci J"},{"issue":"4","key":"825_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/AOG.0000000000002853","volume":"132","author":"EY Adashi","year":"2018","unstructured":"Adashi EY, Gutman R. Delayed Childbearing as a Growing, Previously Unrecognized Contributor to the National Plural Birth Excess. Obstet Gynecol. 2018;132(4):999\u20131006.","journal-title":"Obstet Gynecol"},{"key":"825_CR30","doi-asserted-by":"crossref","unstructured":"Mathews TJ, Brady H. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief. 2009;21:1\u20138.","DOI":"10.1037\/e665262010-001"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00825-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-021-00825-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00825-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T22:02:33Z","timestamp":1625004153000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-021-00825-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1186\/s13048-021-00825-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee Board of the Shengjing Hospital of China Medical University. Informed consent was not required due to the retrospective review design of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}